Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus J Riemenschneider

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
International Journal of Molecular Sciences|April 1, 2009
Molecular neuropathology of gliomasMarkus J Riemenschneider, Guido Reifenberger
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|March 27, 2009
Astrocytic tumorsMarkus J Riemenschneider, Guido Reifenberger
Current Opinion in Neurology|September 11, 2009
Novel insights into the pathogenesis of gliomas based on large-scale molecular profiling approachesMarkus J Riemenschneider, Guido Reifenberger
International Journal of Cancer|February 28, 2008
Frequent biallelic inactivation and transcriptional silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors with 1p lossMarkus J Riemenschneider, Julia Reifenberger, Guido Reifenberger
The Lancet. Neurology|November 18, 2006
Histological classification and molecular genetics of meningiomasMarkus J Riemenschneider, Arie Perry, Guido Reifenberger
Acta Neuropathologica|January 20, 2004
Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomasMarkus J Riemenschneider, Timmo H Koy, Guido Reifenberger
International Journal of Cancer|March 18, 2003
Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification targetMarkus J Riemenschneider, Christiane B Knobbe, Guido Reifenberger
Targeted Oncology|August 21, 2010
MGMT promoter methylation in malignant gliomasMarkus J Riemenschneider, Monika E Hegi, Guido Reifenberger
Brain Pathology (Zurich, Switzerland)|November 20, 2009
Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomasDimitri Barski, Marietta Wolter, Guido Reifenberger, et al.
Brain Pathology (Zurich, Switzerland)|September 24, 2011
Unraveling the glioma epigenome: from molecular mechanisms to novel biomarkers and therapeutic targetsBastian Malzkorn, Marietta Wolter, Markus J Riemenschneider, et al.
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
International Journal of Molecular Sciences|April 1, 2009
Molecular neuropathology of gliomasMarkus J Riemenschneider, Guido Reifenberger
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|March 27, 2009
Astrocytic tumorsMarkus J Riemenschneider, Guido Reifenberger
Current Opinion in Neurology|September 11, 2009
Novel insights into the pathogenesis of gliomas based on large-scale molecular profiling approachesMarkus J Riemenschneider, Guido Reifenberger
International Journal of Cancer|February 28, 2008
Frequent biallelic inactivation and transcriptional silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors with 1p lossMarkus J Riemenschneider, Julia Reifenberger, Guido Reifenberger
The Lancet. Neurology|November 18, 2006
Histological classification and molecular genetics of meningiomasMarkus J Riemenschneider, Arie Perry, Guido Reifenberger
Acta Neuropathologica|January 20, 2004
Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomasMarkus J Riemenschneider, Timmo H Koy, Guido Reifenberger
International Journal of Cancer|March 18, 2003
Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification targetMarkus J Riemenschneider, Christiane B Knobbe, Guido Reifenberger
Targeted Oncology|August 21, 2010
MGMT promoter methylation in malignant gliomasMarkus J Riemenschneider, Monika E Hegi, Guido Reifenberger
Brain Pathology (Zurich, Switzerland)|November 20, 2009
Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomasDimitri Barski, Marietta Wolter, Guido Reifenberger, et al.
Brain Pathology (Zurich, Switzerland)|September 24, 2011
Unraveling the glioma epigenome: from molecular mechanisms to novel biomarkers and therapeutic targetsBastian Malzkorn, Marietta Wolter, Markus J Riemenschneider, et al.
Pageof 14